Ondine Biomedical Inc. (OBI.L)
GBp 10.2
(-0.49%)
GBp 10.2
(-0.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -14.12 Million CAD | 19.0% |
| 2022 | -18.84 Million CAD | -3.55% |
| 2021 | -16.84 Million CAD | -17.97% |
| 2020 | -14.56 Million CAD | -13.37% |
| 2019 | -12.59 Million CAD | 19.33% |
| 2018 | -15.61 Million CAD | -186.42% |
| 2017 | -5.45 Million CAD | 0.0% |
| 2010 | -3.88 Million CAD | 11.22% |
| 2009 | -4.53 Million CAD | 55.14% |
| 2008 | -9.74 Million CAD | 24.13% |
| 2007 | -12.84 Million CAD | -6.48% |
| 2006 | -12.06 Million CAD | -37.68% |
| 2005 | -8.76 Million CAD | 0.0% |
| 2003 | -82.94 Thousand CAD | -105.9% |
| 2002 | 1.4 Million CAD | 1975.77% |
| 2001 | -74.94 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.5 Million GBP | 0.0% |
| 2023 Q2 | -4.64 Million GBP | 0.0% |
| 2023 Q4 | -3.83 Million GBP | 0.0% |
| 2023 FY | - CAD | 19.0% |
| 2022 FY | - CAD | -3.55% |
| 2022 Q2 | -4.95 Million GBP | 0.0% |
| 2022 Q4 | -7.31 Million GBP | 0.0% |
| 2021 FY | - CAD | -17.97% |
| 2020 FY | - CAD | -13.37% |
| 2019 FY | - CAD | 19.33% |
| 2018 FY | - CAD | -186.42% |
| 2017 FY | - CAD | 0.0% |
| 2011 Q1 | -937.15 Thousand CAD | -8.33% |
| 2011 Q2 | -1.12 Million CAD | -20.08% |
| 2010 Q2 | -1.1 Million CAD | 4.23% |
| 2010 FY | - CAD | 11.22% |
| 2010 Q1 | -1.15 Million CAD | -22.94% |
| 2010 Q4 | -865.1 Thousand CAD | -4.87% |
| 2010 Q3 | -824.91 Thousand CAD | 25.26% |
| 2009 Q4 | -937.44 Thousand CAD | -172.21% |
| 2009 FY | - CAD | 55.14% |
| 2009 Q1 | -1.39 Million CAD | 26.54% |
| 2009 Q2 | -1.69 Million CAD | -21.36% |
| 2009 Q3 | -344.38 Thousand CAD | 79.68% |
| 2008 Q1 | -2.47 Million CAD | 7.51% |
| 2008 FY | - CAD | 24.13% |
| 2008 Q3 | -2.98 Million CAD | -24.71% |
| 2008 Q4 | -1.9 Million CAD | 36.28% |
| 2008 Q2 | -2.39 Million CAD | 3.21% |
| 2007 Q3 | -3.02 Million CAD | 17.8% |
| 2007 FY | - CAD | -6.48% |
| 2007 Q4 | -2.67 Million CAD | 11.59% |
| 2007 Q1 | -3.47 Million CAD | 0.81% |
| 2007 Q2 | -3.67 Million CAD | -5.81% |
| 2006 Q3 | -2.74 Million CAD | 6.27% |
| 2006 FY | - CAD | -37.68% |
| 2006 Q4 | -3.5 Million CAD | -27.71% |
| 2006 Q2 | -2.92 Million CAD | -1.16% |
| 2006 Q1 | -2.89 Million CAD | -20.56% |
| 2005 FY | - CAD | 0.0% |
| 2005 Q1 | -1.85 Million CAD | -178.82% |
| 2005 Q2 | -2.32 Million CAD | -25.5% |
| 2005 Q3 | -2.18 Million CAD | 6.23% |
| 2005 Q4 | -2.39 Million CAD | -9.96% |
| 2004 Q3 | -1.55 Million CAD | -22.14% |
| 2004 Q4 | -665.08 Thousand CAD | 57.13% |
| 2004 Q2 | -1.27 Million CAD | 28.33% |
| 2004 Q1 | -1.77 Million CAD | -3566.0% |
| 2003 FY | - CAD | -105.9% |
| 2003 Q1 | -20.16 Thousand CAD | -1160.98% |
| 2003 Q4 | -48.34 Thousand CAD | -41.03% |
| 2003 Q3 | -34.28 Thousand CAD | -27.41% |
| 2003 Q2 | -26.9 Thousand CAD | -33.44% |
| 2002 Q1 | -14.16 Thousand CAD | 41.17% |
| 2002 Q3 | -8174.00 CAD | 64.74% |
| 2002 Q4 | -1599.00 CAD | 80.44% |
| 2002 FY | - CAD | 1975.77% |
| 2002 Q2 | -23.18 Thousand CAD | -63.65% |
| 2001 Q4 | -24.07 Thousand CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|